Endocrine Today has compiled a list of the top five hormone therapy news reports posted in 2017.
Healio.com/Endocrinology readers were interested in research presented at the Endocrine Society Annual Meeting, the American Association of Clinical Endocrinologists Annual Meeting and the North American Menopause Society Annual Meeting.
Testosterone replacement therapy lowers mortality, CV risk in secondary hypogonadism
AUSTIN, Texas — Testosterone replacement therapy may lower the risk for myocardial infarction, stroke and all-cause mortality in men with secondary hypogonadism. Read more.
Breast development modest with cross-sex hormonal treatment in transgender women
ORLANDO, Fla. — Breast development in transgender women treated with cross-sex hormonal therapy occurs primarily in the first 6 months of administration and stabilizes with no increase during the last 6 months, according to research presented here. Read more.
HT misperceptions common among women’s health providers
PHILADELPHIA — A decade after the Women’s Health Initiative clinical trials, misperceptions regarding hormone therapy and gaps in knowledge prevent women from accessing treatment for menopausal symptoms, according to a study presented at the Annual Meeting of the North American Menopause Society. Read more.
Long-term safety data needed for investigational estradiol vaginal
TherapeuticsMD recently received a Complete Response Letter from the FDA in reply to its New Drug Application for TX-004HR, an investigational applicator-free estradiol vaginal softgel capsule for the treatment of moderate to severe vaginal pain during sexual intercourse, according to a company press release. Read more.
HT remains most effective first-line choice for menopausal symptoms
PHILADELPHIA — Hormone therapy for menopausal women is one of the best examples of precision medicine in clinical practice and remains the most effective first-line treatment for the common symptoms of menopause, according to a speaker here. Read more.